In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ekos' Long, Hard Road

Executive Summary

A stroke therapy company that combines interventional tools, ultrasound, and pharmaceuticals, Ekos has, in its short history, run into just about every problem a medical device start-up can face, from product failures to difficult financings, aborted partnerships to clinical trials that had to be stopped. Ekos isn't quite out of the woods, but it's getting there, and doing so with a strategy that, particularly in its approach to clinical trials, borrows a lot from the pharmaceutical industry.
Advertisement

Related Content

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel